- Citations, last 5 years
- 555
- Works, last 5 years
- 28
- h-index
- 28
- Scientists listed
- 1
- Grants since 2016
- 11
Grants received
2025–2027 · research · R41
Novel AAV gene therapy for treating CNS neuropathy of MPS IIIC
Haiyan Fu · Moog (United States) · funded by National Institutes of Health
2025–2027 · research · R44
Trans-BBB AAV9 gene therapy targeting CNS neuropathy of MPS I
Douglas M Mccarty · Moog (United States) · funded by National Institutes of Health
2024–2025 · research · R44
Development of gene therapy product for treating MPS IIIB
Douglas M Mccarty · Moog (United States) · funded by National Institutes of Health
2024–2027 · research · R44
Development of gene therapy product for treating MPS IIIB
Douglas M Mccarty · Moog (United States) · funded by National Institutes of Health
2023–2026 · research · R44
Protein depleting pre-existing antibodies for viral gene therapy
Douglas M Mccarty · Moog (United States) · funded by National Institutes of Health
2023–2024 · research · R44
Protein depleting pre-existing antibodies for viral gene therapy
Douglas M Mccarty · Moog (United States) · funded by National Institutes of Health
2023–2026 · research · R44
Protein depleting pre-existing antibodies for viral gene therapy
Douglas M Mccarty · Moog (United States) · funded by National Institutes of Health
2022–2025 · research · R41
Develop AAV9 gene replacement therapy for treating MPS I
Haiyan Fu · Moog (United States) · funded by National Institutes of Health
2022–2024 · research · R41
Develop AAV9 gene replacement therapy for treating MPS I
Haiyan Fu · Moog (United States) · funded by National Institutes of Health
2020–2023 · research · R41
Development of gene therapy product for treating MPS IIIB
Haiyan Fu · Moog (United States) · funded by National Institutes of Health
2020–2022 · research · R41
Development of gene therapy product for treating MPS IIIB
Haiyan Fu · Moog (United States) · funded by National Institutes of Health